Elevated expression of the EZH2 gene in CALR-mutated patients with primary myelofibrosis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3287-8
Abstract: Primary myelofibrosis (PMF) is one of the BCR/ABL-negative myeloproliferative neoplasms (MPNs), characterized by the diffuse fibrous hyperproliferation, bone marrow osteosclerosis, extramedullary hematopoiesis, and marked splenomegaly. The patients with PMF have an insidious onset, a long… read more here.
Keywords: mutated patients; primary myelofibrosis; calr mutated; expression ezh2 ... See more keywords
High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13050876
Abstract: Background: Hepatocellular carcinoma (HCC) is the predominant form of liver cancer and is accompanied by a complex regulatory network. Increasing evidence suggests that an abnormal gene expression of EZH2 is associated with HCC progression. However,… read more here.
Keywords: hepatocellular carcinoma; expression; poor prognosis; analysis ... See more keywords
Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells
Sign Up to like & getrecommendations! Published in 2017 at "Oncology Letters"
DOI: 10.3892/ol.2017.7171
Abstract: Expression of enhancer of zeste homolog 2 (EZH2) has been implicated in cancer pathology, but research on its mechanistic activity is limited. The present study sought to assess the levels expression of EZH2 in patients… read more here.
Keywords: expression; endometrial carcinoma; proliferation invasion; expression ezh2 ... See more keywords